Our Products

The HeartPad® device is not for sale in the United States. It is delivered and positioned adjacent to the heart using video guidance for minimally invasive ablation procedures and is intended to ablate generally large contiguous areas of cardiac tissue, such as atrial tissue, with each individual application. Once in position the device is expanded by inflating its insulation balloon. This causes the unique ablating surface to come into contact with an external (epicardial) surface of the heart that is targeted for ablation. System sensors provide data to help direct ablation therapy.  Once an appropriate target is identified ultra-cold helium gas is driven through the unique ablating surface, attaching the ablation pad to the contacted heart by a process called cryo-adhesion.  The contacted surface of the heart is ablated while adjacent areas are protected from ablation injury by the insulation balloon. After ablation is completed warm gas is supplied to thaw the ablation pad which reverses the cryo-adhesion and allows re-positioning of the device where additional ablation is required. Once the desired degree of ablation is completed the HeartPad® device is collapsed and withdrawn from the pericardial cavity.

Introducing the HeartPad®

DEVELOPMENT PIPELINE:

Coronary Sinus Ablation

Novel Vascular Graft

Left Atrial Appendage Management

About Ablation

Ablation is a general methodology to destroy or disable abnormal tissue in the body that is causing disease or dysfunction. Ablation therapies have been used to destroy cancerous tumors and to disrupt electrical energy that causes heart rhythm disturbances. Many energy sources can be used for ablation, including extreme heat, microwave, ultrasound, laser, and cryothermy (freezing).